Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvonne Andersson

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Omega|July 13, 2017
Blogs and the Art of Dying: Blogging With, and About, Severe Cancer in Late Modern Swedish SocietyYvonne Andersson
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 16, 2019
Generic substitution of drugs in hospitalsRolf Johansen, Yvonne Andersson
The Journal of Infection|October 19, 2005
The epidemiology of travel-associated shigellosis--regional risks, seasonality and serogroupsKarl Ekdahl, Yvonne Andersson
BMC Infectious Diseases|December 1, 2004
Regional risks and seasonality in travel-associated campylobacteriosisKarl Ekdahl, Yvonne Andersson
Acta Crystallographica. Section C, Crystal Structure Communications|March 7, 2009
Sc(2)MgGa(2) and Y(2)MgGa(2)Martin Sahlberg, Yvonne Andersson
The American Journal of Tropical Medicine and Hygiene|June 21, 2005
Imported giardiasis: impact of international travel, immigration, and adoptionKarl Ekdahl, Yvonne Andersson
Ochsner Journal|May 24, 2011
Immunotoxins: a promising treatment modality for metastatic melanoma?Karianne Risberg, Oystein Fodstad, Yvonne Andersson
International Journal of Cancer|April 8, 2009
The melanoma specific 9.2.27PE immunotoxin efficiently kills melanoma cells in vitroKarianne Risberg, Øystein Fodstad, Yvonne Andersson
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 7, 2010
Anti-melanoma activity of the 9.2.27PE immunotoxin in dacarbazine resistant cellsKarianne Risberg, Oystein Fodstad, Yvonne Andersson
Plos One|September 15, 2011
Synergistic anticancer effects of the 9.2.27PE immunotoxin and ABT-737 in melanomaKarianne Risberg, Øystein Fodstad, Yvonne Andersson
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Omega|July 13, 2017
Blogs and the Art of Dying: Blogging With, and About, Severe Cancer in Late Modern Swedish SocietyYvonne Andersson
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 16, 2019
Generic substitution of drugs in hospitalsRolf Johansen, Yvonne Andersson
The Journal of Infection|October 19, 2005
The epidemiology of travel-associated shigellosis--regional risks, seasonality and serogroupsKarl Ekdahl, Yvonne Andersson
BMC Infectious Diseases|December 1, 2004
Regional risks and seasonality in travel-associated campylobacteriosisKarl Ekdahl, Yvonne Andersson
Acta Crystallographica. Section C, Crystal Structure Communications|March 7, 2009
Sc(2)MgGa(2) and Y(2)MgGa(2)Martin Sahlberg, Yvonne Andersson
The American Journal of Tropical Medicine and Hygiene|June 21, 2005
Imported giardiasis: impact of international travel, immigration, and adoptionKarl Ekdahl, Yvonne Andersson
Ochsner Journal|May 24, 2011
Immunotoxins: a promising treatment modality for metastatic melanoma?Karianne Risberg, Oystein Fodstad, Yvonne Andersson
International Journal of Cancer|April 8, 2009
The melanoma specific 9.2.27PE immunotoxin efficiently kills melanoma cells in vitroKarianne Risberg, Øystein Fodstad, Yvonne Andersson
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 7, 2010
Anti-melanoma activity of the 9.2.27PE immunotoxin in dacarbazine resistant cellsKarianne Risberg, Oystein Fodstad, Yvonne Andersson
Plos One|September 15, 2011
Synergistic anticancer effects of the 9.2.27PE immunotoxin and ABT-737 in melanomaKarianne Risberg, Øystein Fodstad, Yvonne Andersson
Pageof 10